OPHLF OTC
Ono Pharmaceutical Co., Ltd.
1W: -5.6%
1M: +2.7%
3M: +10.7%
YTD: +16.2%
1Y: +44.4%
3Y: -18.3%
5Y: -21.1%
$14.95
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.11T
+4.6% ▲
5Y CAGR: +8.3%
Total Liabilities
$251.4B
-8.8% ▼
5Y CAGR: +18.9%
Shareholders Equity
$856.1B
+9.4% ▲
5Y CAGR: +6.1%
Cash & Investments
$238.6B
+13.4% ▲
5Y CAGR: +17.8%
Total Debt
$121.7B
-17.0% ▼
5Y CAGR: +68.2%
Net Debt
-$116.8B
-101.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $69.1B | $96.1B | $166.1B | $204.6B | $238.5B |
| Short-Term Investments | $47.9B | $68.2B | $38.5B | $5.8B | $60M |
| Cash & ST Investments | $117.0B | $164.3B | $204.6B | $210.4B | $238.6B |
| Net Receivables | $99.8B | $114.4B | $136.1B | $135.0B | $146.9B |
| Inventory | $41.8B | $44.8B | $48.6B | $74.9B | $57.8B |
| Other Current Assets | $11.7B | $11.1B | $9.6B | $34.8B | $28.0B |
| Total Current Assets | $281.3B | $345.1B | $413.6B | $455.1B | $471.3B |
| Property, Plant & Equip. | $112.1B | $108.4B | $104.8B | $105.7B | $102.1B |
| Goodwill & Intangibles | $64.7B | $69.1B | $57.3B | $351.2B | $378.6B |
| Long-Term Investments | $204.6B | $252.7B | $294.4B | $88.6B | $101.9B |
| Other Non-Current Assets | $51.4B | $71.5B | $43.7B | $12.4B | $3.5B |
| Total Non-Current Assets | $457.9B | $537.3B | $500.1B | $608.9B | $642.2B |
| Total Assets | $739.2B | $882.4B | $913.7B | $1.06T | $1.11T |
| — Liabilities — | |||||
| Accounts Payable | $49.7B | $66.8B | $60.7B | $89.3B | $63.3B |
| Short-Term Debt | -$2.2B | -$35.2B | $0 | $30.0B | $35.4B |
| Deferred Revenue | $2.2B | $35.2B | $0 | $0 | $0 |
| Other Current Liabilities | $3.1B | $41.9B | $27.1B | $21.7B | $17.4B |
| Total Current Liabilities | $65.9B | $122.9B | $103.6B | $148.3B | $164.7B |
| Long-Term Debt | $0 | $0 | $0 | $105.0B | $75.5B |
| Other Non-Current Liab. | $0 | $0 | $3.9B | $3.2B | $2.9B |
| Total Non-Current Liabilities | $11.6B | $11.7B | $11.4B | $127.5B | $86.8B |
| Total Liabilities | $77.5B | $134.6B | $115.1B | $275.8B | $251.4B |
| — Equity — | |||||
| Common Stock | $17.4B | $17.4B | $17.4B | $17.4B | $17.5B |
| Retained Earnings | $644.8B | $709.9B | $768.2B | $790.9B | $835.3B |
| Accumulated OCI | $51.2B | $51.7B | $53.2B | $19.8B | $49.0B |
| Total Stockholders Equity | $655.9B | $741.9B | $793.0B | $782.5B | $856.1B |
| Total Liabilities & Equity | $739.2B | $882.4B | $913.7B | $1.06T | $1.11T |
| — Key Metrics — | |||||
| Total Debt | $8.8B | $9.2B | $8.9B | $146.7B | $121.7B |
| Net Debt | -$60.3B | -$87.0B | -$157.3B | -$57.9B | -$116.8B |
| Total Investments | $252.5B | $320.9B | $332.8B | $94.4B | $102.0B |